Fixed-bed bioreactor scale-X™ nexo

laboratoryfor scientific researchscreening

Tiny but Mighty: Sophisticated innovation for early-stage research The 0.5 m² scale-X™ nexo bioreactor redefines what’s possible in early-stage research – delivering premium sophistication in a compact design. Its scalable platform seamlessly supports direct scale-up to 600 m² with minimal adaptations, ensuring a smooth, accelerated, and low-risk process from small to large-scale production. A solution for early process development Take your scale-X nexo system to the next level Compatible with the Skaia™ vision software for advanced cell monitoring and prediction, the scale-X nexo bioreactor delivers unmatched performance for fast, reliable, and scalable bioprocessing. Reduce costs per run by up to 60%1 Reach cost-effective bioprocess development with this small-scale, low-footprint scale-X™ nexo bioreactor system. Developed for early-stage screening and research, the bioreactor allows cells to grow on a surface of 0,5 m2 in a volume of only 75mL. Such miniaturization reduces the consumption of media, reagents, and seed-train efforts. Combined with high-value consumables, this results in significantly lower cost per run.1 Accelerate your path to market with seamless scalability Develop your bioprocess effortlessly from research to commercial manufacturing in the same platform. Scalable by design, the technology enables quick transition between scale-X nexo (0,5 m²), scale-X carbo (10-30 m²) and scale-X nitro (200-600 m²) bioreactors. By maintaining homogeneous cell distribution, high cell density and productivity across scales, accelerate time to market with fewer runs, reduced time and minimized effort.